GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Operating Margin %

Intravenous Infusions (XGHA:IIL) Operating Margin % : 0.00% (As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Intravenous Infusions's Operating Income for the six months ended in . 20 was GHS0.00 Mil. Intravenous Infusions's Revenue for the six months ended in . 20 was GHS0.00 Mil. Therefore, Intravenous Infusions's Operating Margin % for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Intravenous Infusions's Operating Margin % or its related term are showing as below:


XGHA:IIL's Operating Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.9
* Ranked among companies with meaningful Operating Margin % only.

Intravenous Infusions's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Intravenous Infusions's Operating Income for the six months ended in . 20 was GHS0.00 Mil.


Intravenous Infusions Operating Margin % Historical Data

The historical data trend for Intravenous Infusions's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Operating Margin % Chart

Intravenous Infusions Annual Data
Trend
Operating Margin %

Intravenous Infusions Semi-Annual Data
Operating Margin %

Competitive Comparison of Intravenous Infusions's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intravenous Infusions's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Operating Margin % falls into.


;
;

Intravenous Infusions Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Intravenous Infusions's Operating Margin % for the fiscal year that ended in . 20 is calculated as

Operating Margin %=Operating Income (A: . 20 ) / Revenue (A: . 20 )
= /
= %

Intravenous Infusions's Operating Margin % for the quarter that ended in . 20 is calculated as

Operating Margin %=Operating Income (Q: . 20 ) / Revenue (Q: . 20 )
= /
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intravenous Infusions  (XGHA:IIL) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Intravenous Infusions Operating Margin % Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.